Strategy We focus on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide flexible, long term capital to help accelerate their ideas into important new treatments for patients. Investment criteria We are science led investors, focusing on innovative technologies in areas of high unmet need. Unconstrained by institution, geography or stage of company development we have the ability to source the best life science innovation without restriction. Focus Novel therapeutics with first or best in class approach. We focus on on investing in high impact science, with the potential to dramatically improve outcomes for patients. Source Unconstrained approach to sourcing innovation. Arix benefits from extensive global networks including deep venture capital and biotech networks, pharmaceutical and academic partners Geography Extensive global networks provide easy access to the best life science innovation across the globe Development Stage Flexible to the point of entry. We invest in seed stage companies, preclinical and clinical stage assets; private or public ARIX BIOSCIENCE About Arix The Team Portfolio Insights News & Events Contact INVESTOR RELATIONS Results Centre Financial Calendar Regulatory News Document Library Analysts & Advisors Shareholder Information META Privacy Policy Terms of use Cookie Policy STAY UP TO DATE Sign up to receive regulatory news and results SUBSCRIBE Arix Bioscience plc, registered in England and Wales with company number 09777975 Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom Website by Ether

Results Centre Investor Relations Navigation Annual Results Podcast Robert Lyne, COO, discusses 2020 highlights Latest Presentation 2021 Interim Results Presentation Annual Report For the year ended 31 Dec 2020 ARIX BIOSCIENCE About Arix The Team Portfolio Insights News & Events Contact INVESTOR RELATIONS Results Centre Financial Calendar Regulatory News Document Library Analysts & Advisors Shareholder Information META Privacy Policy Terms of use Cookie Policy STAY UP TO DATE Sign up to receive regulatory news and results SUBSCRIBE Arix Bioscience plc, registered in England and Wales with company number 09777975 Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom Website by Ether

Analyst & Advisers DOWNLOAD HARDMAN RESEARCH HERE Investor Relations Navigation ARIX BIOSCIENCE About Arix The Team Portfolio Insights News & Events Contact INVESTOR RELATIONS Results Centre Financial Calendar Regulatory News Document Library Analysts & Advisors Shareholder Information META Privacy Policy Terms of use Cookie Policy STAY UP TO DATE Sign up to receive regulatory news and results SUBSCRIBE Arix Bioscience plc, registered in England and Wales with company number 09777975 Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom Website by Ether